Chief Physician, Professor, Doctoral and Postdoctoral Supervisor at Peking University Cancer Hospital; Founder and Chief Expert of the Interventional Therapy Department. Specialties: Interventional minimally invasive treatments for tumors (embolization, ablation), percutaneous recanalization for vascular stenosis or occlusion, recanalization for stenosis or occlusion of non-vascular hollow organs (bile ducts, digestive tract, trachea, ureters, etc.), uterine fibroid embolization, and treatment of obstructive jaundice and hemorrhage. Concurrent Positions: Founder and First/Second-Term Chair of the Tumor Interventional Therapy Committee of the Chinese Anti-Cancer Association; Chair of the Expert Committee of the Tumor Interventional Therapy Committee of the Chinese Anti-Cancer Association; Chair of the Tumor Interventional Therapy Committee of the Beijing Anti-Cancer Association. Former President of the World Conference on Interventional Oncology (WCIO); Lifetime Honorary President of the World Ablation Therapy Association (WATA); Founder and President of the Asia-Pacific Society of Interventional Oncology (APSIO); Director of the China-Japan Science and Technology Association; Expert Reviewer for the National Science and Technology Award; Expert Reviewer for the Natural Science Foundation; Expert for the National Health Commission Talent Evaluation Question Bank; Expert for the Short-Term Medical Practice Examination for Foreign Physicians. Visiting Professor: Massachusetts General Hospital (Harvard University), Dotter Interventional Radiology Institute, SUNY Downstate Medical Center, New Jersey Medical School, Royal North Shore Hospital (Sydney, Australia), and Kumamoto University Hospital (Japan).